VICKIE S REED
CIK 1405637 · SVP, Chief Accounting Officer · last filed 2025-12-17
VICKIE S REED is a SVP, Chief Accounting Officer who has filed 16 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for EVOK, was dated Dec 17, 2025. Across all open-market trades the lifetime net is −$388.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
16
-$388.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc (EVOK) Delisted | Director | — | $11.00 | — | $0 | 7 | 2025-12-17 |
| DMK PHARMACEUTICALS Corp (ADMP) Delisted | Director | — | $0.78 | — | $0 | 1 | 2022-05-26 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | SVP, Chief Accounting Officer | 15,369 | $58.70 | $902.2K | -$388.4K | 8 | 2022-01-18 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-17 | Evoke Pharma Inc (EVOK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-05-22 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | DMK PHARMACEUTICALS Corp (ADMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-28 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | +4,844 | -$64.2K | EDGAR |
| 2022-01-07 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −345 | -$46.9K | EDGAR |
| 2022-01-06 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −758 | -$112.0K | EDGAR |